Suchergebnisse - "Corsini, Lidia Rita"

PubPharm (33)

1

The Italian Rare Biliary tract Cancer initiative (IRaBiCa) : A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)

enthalten in: Tumori | 2024

von Speranza, D. | Sapuppo, E. | Aprile, G. | +34

2

Clinical relevance of exosome-derived microRNAs in Ovarian Cancer : Looking for new tumor biological fingerprints

enthalten in: Critical reviews in oncology/hematology | 2024

von Fanale, D. | Corsini, L. | Bono, M. | +18

3

Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors : Still looking through a dirty glass window?

enthalten in: Cancer treatment reviews | 2023

von Incorvaia, L. | Perez, A. | Marchetti, C. | +21

4

Potential agnostic role of BRCA alterations in patients with several solid tumors : One for all, all for one?

enthalten in: Critical reviews in oncology/hematology | 2023

von Fanale, D. | Corsini, L. | Pedone, E. | +11

5

Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer

enthalten in: BMC cancer | 2023

von Fanale, D. | Brando, C. | Corsini, L. | +18

6

The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy : Strengths and Weaknesses of Surrogate Endpoints

enthalten in: Biomedicines | 2022

von Giuffrida, P. | Celsa, C. | Antonucci, M. | +13

7

Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer

enthalten in: Cancers | 2022

von Fanale, D. | Dimino, A. | Pedone, E. | +10

8

MUTYH-associated tumor syndrome : The other face of MAP

enthalten in: Oncogene | 2022

von Magrin, L. | Fanale, D. | Brando, C. | +10

9

Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?

enthalten in: Critical reviews in oncology/hematology | 2022

von Fanale, D. | Corsini, L. | Scalia, R. | +15

10

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?

enthalten in: Frontiers in oncology | 2022

von Fanale, D. | Corsini, L. | Brando, C. | +15